Tech Company Financing Transactions
Curtana Pharmaceuticals Funding Round
Private investors participated in a $200 thousand funding round for Curtana Pharmaceuticals. The round was announced on 6/9/2014.
Transaction Overview
Company Name
Announced On
6/9/2014
Transaction Type
Online Capital
Online Capital
Online Capital
Amount
$200,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will be used to jumpstartthe program prior to a much larger Series A round of $8 millionto $10 million that is expected to open in September.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4200 Marathon Blvd. 200
Austin, TX 78756
USA
Austin, TX 78756
USA
Phone
Undisclosed
Website
Email Address
Overview
Curtana Pharmaceuticals is an innovative pre-clinical stage drug development company dedicated to addressing the unmet need of patients with glioblastoma by developing highly-effective, first-in-class, small molecule therapeutics that specifically target cancer stem cells in the brain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gregory Stein
Vice President
Graham Beaton
Vice President
Daniel Pertschuk
VP - R & D
Gordon Alton
Browse more venture capital transactions:
Prev: 6/9/2014: GoPath venture capital transaction
Next: 6/9/2014: Brainstorm Health Services venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs